Professor of Community Health Sciences at Boston University School of Public Health
Con to the question "Should Marijuana Be a Medical Option?"
"Medical cannabis regulations make unregulated products available to be inhaled in smoke or vapor, applied topically as oils and creams, eaten in edibles, or taken orally or sublingually. The demonstrated efficacy and safety of these products should not be labeled as medical. 'Budtenders,' not pharmacists, physicians, or other clinicians, make clinical recommendations...
Cannabis and cannabis-derived medications merit further research, and such scientific work will likely yield useful results. This does not mean that medical cannabis recommendations should be made without the evidence base demanded for other treatments."
Cowritten with Keith Humphries, "Should Physicians Recommend Replacing Opioids with Cannabis?," JAMA, Feb. 1, 2019
Key Experts Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
Professor, Community Health Sciences, Boston University School of Public Health
Chair, Department of Community Health Sciences, Boston University School of Public Health
Editor Emeritus, Addiction Science & Clinical Practice
Senior Editor, Journal of Addiction Medicine
Associate Editor, Journal of the American Medical Association
Former Director, Boston Medical Center's Clinical Addiction Research and Education (CARE) Unit
MPH (Master of Public Health), Harvard University, 1993